31998078|t|Allopregnanolone Modulates GABAAR-Dependent CaMKIIdelta3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage.
31998078|a|Allopregnanolone (APalpha), as a functional neurosteroid, exhibits the neuroprotective effect on neurodegenerative diseases such as Parkinson's disease (PD) through gamma-aminobutyric acid A receptor (GABAAR), but it has not been completely understood about its molecular mechanisms. In order to investigate the neuroprotective effect of APalpha, as well as to clarify its possible molecular mechanisms, SH-SY5Y neuronal cell lines were incubated with 6-hydroxydopamine (6-OHDA), which has been widely used as an in vitro model for PD, along with APalpha alone or in combination with GABAAR antagonist (bicuculline, Bic), intracellular Ca2+ chelator (EGTA) and voltage-gated L-type Ca2+ channel blocker (Nifedipine). The viability, proliferation, and differentiation of SH-SY5Y cells, the expression levels of calmodulin (CaM), Ca2+/calmodulin-dependent protein kinase II delta3 (CaMKIIdelta3), cyclin-dependent kinase-1 (CDK1) and brain-derived neurotrophic factor (BDNF), as well as the interaction between CaMKIIdelta3 and CDK1 or BDNF, were detected by morphological and molecular biological methodology. Our results found that the cell viability and the number of tyrosine hydroxylase (TH), bromodeoxyuridine (BrdU) and TH/BrdU-positive cells in 6-OHDA-treated SH-SY5Y cells were significantly decreased with the concomitant reduction in the expression levels of aforementioned proteins, which were ameliorated following APalpha administration. In addition, Bic could further increase the number of TH or BrdU-positive cells as well as the expression levels of aforementioned proteins except for TH/BrdU-double positive cells, while EGTA and Nifedipine could attenuate the expression levels of CaM, CaMKIIdelta3 and BDNF. Moreover, there existed a direct interaction between CaMKIIdelta3 and CDK1 or BDNF. As a result, APalpha-induced an increase in the number of TH-positive SH-SY5Y cells might be mediated through GABAAR via Ca2+/CaM/CaMKIIdelta3/BDNF (CDK1) signaling pathway, which would ultimately facilitate to elucidate PD pathogenesis and hold a promise as an alternative therapeutic target for PD.
31998078	0	16	Allopregnanolone	Chemical	MESH:D011280
31998078	61	65	BDNF	Gene	627
31998078	77	84	SH-SY5Y	CellLine	CVCL:0019
31998078	99	105	6-OHDA	Chemical	MESH:D016627
31998078	122	138	Allopregnanolone	Chemical	MESH:D011280
31998078	140	147	APalpha	Gene	2028
31998078	219	245	neurodegenerative diseases	Disease	MESH:D019636
31998078	254	273	Parkinson's disease	Disease	MESH:D010300
31998078	275	277	PD	Disease	MESH:D010300
31998078	460	467	APalpha	Gene	2028
31998078	526	533	SH-SY5Y	CellLine	CVCL:0019
31998078	574	591	6-hydroxydopamine	Chemical	MESH:D016627
31998078	593	599	6-OHDA	Chemical	MESH:D016627
31998078	654	656	PD	Disease	MESH:D010300
31998078	669	676	APalpha	Gene	2028
31998078	725	736	bicuculline	Chemical	MESH:D001640
31998078	738	741	Bic	Chemical	MESH:C100119
31998078	758	762	Ca2+	Chemical	-
31998078	773	777	EGTA	Chemical	MESH:D004533
31998078	783	824	voltage-gated L-type Ca2+ channel blocker	Chemical	-
31998078	826	836	Nifedipine	Chemical	MESH:D009543
31998078	892	899	SH-SY5Y	CellLine	CVCL:0019
31998078	932	942	calmodulin	Gene	801
31998078	944	947	CaM	Gene	801
31998078	1017	1042	cyclin-dependent kinase-1	Gene	983
31998078	1044	1048	CDK1	Gene	983
31998078	1054	1087	brain-derived neurotrophic factor	Gene	627
31998078	1089	1093	BDNF	Gene	627
31998078	1148	1152	CDK1	Gene	983
31998078	1156	1160	BDNF	Gene	627
31998078	1291	1311	tyrosine hydroxylase	Gene	7054
31998078	1313	1315	TH	Gene	7054
31998078	1318	1335	bromodeoxyuridine	Chemical	MESH:D001973
31998078	1337	1341	BrdU	Chemical	MESH:D001973
31998078	1347	1349	TH	Gene	7054
31998078	1350	1354	BrdU	Chemical	MESH:D001973
31998078	1373	1379	6-OHDA	Chemical	MESH:D016627
31998078	1388	1395	SH-SY5Y	CellLine	CVCL:0019
31998078	1548	1555	APalpha	Gene	2028
31998078	1585	1588	Bic	Chemical	MESH:C100119
31998078	1626	1628	TH	Gene	7054
31998078	1632	1636	BrdU	Chemical	MESH:D001973
31998078	1723	1725	TH	Gene	7054
31998078	1726	1730	BrdU	Chemical	MESH:D001973
31998078	1760	1764	EGTA	Chemical	MESH:D004533
31998078	1769	1779	Nifedipine	Chemical	MESH:D009543
31998078	1821	1824	CaM	Gene	801
31998078	1843	1847	BDNF	Gene	627
31998078	1919	1923	CDK1	Gene	983
31998078	1927	1931	BDNF	Gene	627
31998078	1946	1953	APalpha	Gene	2028
31998078	1991	1993	TH	Gene	7054
31998078	2003	2010	SH-SY5Y	CellLine	CVCL:0019
31998078	2054	2058	Ca2+	Chemical	-
31998078	2059	2062	CaM	Gene	801
31998078	2076	2080	BDNF	Gene	627
31998078	2082	2086	CDK1	Gene	983
31998078	2154	2156	PD	Disease	MESH:D010300
31998078	2230	2232	PD	Disease	MESH:D010300
31998078	Association	MESH:D010300	2028
31998078	Negative_Correlation	MESH:D009543	801
31998078	Negative_Correlation	MESH:D001640	2028
31998078	Association	MESH:D011280	627
31998078	Negative_Correlation	MESH:D004533	627
31998078	Negative_Correlation	2028	7054
31998078	Association	MESH:D016627	MESH:D010300
31998078	Association	MESH:D016627	627
31998078	Negative_Correlation	MESH:D001973	2028
31998078	Positive_Correlation	MESH:C100119	MESH:D001973
31998078	Negative_Correlation	MESH:D011280	MESH:D016627
31998078	Negative_Correlation	MESH:D004533	801
31998078	Negative_Correlation	MESH:D011280	MESH:D019636
31998078	Positive_Correlation	MESH:C100119	7054
31998078	Positive_Correlation	MESH:D016627	7054
31998078	Negative_Correlation	MESH:D016627	2028
31998078	Association	MESH:C100119	801
31998078	Negative_Correlation	MESH:D011280	MESH:D010300
31998078	Negative_Correlation	MESH:D009543	627

